Galectin Therapeutics Inc. (NASDAQ:GALT)
CAPS Rating:
A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.
RSS Headlines
Fool UK
Recs
Read between the lines !!!